Health-Related Quality of Life and Other Patient-Reported Outcomes in the European Centralized Drug Regulatory Process: A Review of Guidance Documents and Performed Authorizations of Medicinal Products 1995 to 2003
Under an Elsevier user license
open archive
Keywords
drug authorization
EMEA
health-related quality of life
patient perspective
patient-reported outcome
regulatory issues
Cited by (0)
Copyright © 2005 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.